Insurance denials prevent lifesaving care for patients with eating disorders

Anorexia as religion: from the Middle Ages to modern message boards

Humanity's interest in anorexia nervosa can be traced back to the Middle Ages and the rise of "fasting girls." This article explores the history of the eating disorder as a religion. The first recorded anorexics appeared during the 13th century...

Black patients are losing their limbs at a rate triple that of other groups due in large part to inequities in diabetes care and management.

Government watchdog says nursing homes are inappropriately diagnosing schizophrenia

The Department of Health and Human Services Office of Inspector General said in a March 2026 report that nursing homes are incorrectly diagnosing their residents with schizophrenia to mask the facilities' misuse of antipsychotic medications. The drugs, the report states, are being widely used to make staff members' jobs easier and to keep nursing home quality measures high—since antipsychotic use for schizophrenia wouldn't be counted against the facility. (PDF)

Insurance coverage for GLP-1s remains uneven, but Medicare began covering it in some instances in July 2026.

Paperwork errors cost families millions in life-insurance payouts

This podcast episode reveals how human missteps by employers and insurance providers caused hundreds of families who paid life-insurance premiums to be denied millions of dollars in death benefits. A Wall Street Journal reporter breaks down how flaws in the system made this happen.

Some Ozempic users lose their desire to eat

This essay follows a writer whose Ozempic journey involves a dramatic loss of appetite, leading them to stop compulsive snacking and even lose some of the joy of eating. As a result, he becomes fixated on watching food videos and eventually tries to "beat" an all-you-can-eat steak buffet. The experience leaves him feeling disappointed and lacking in desire.

How self-care led to Ozempic's success

Self-care has become a $1.5T economy that idealizes restraint and willpower, leaving behind those who can't shake off human nature. This article explores how Ozempic and similar weight loss medications pick up where self-care left off.

Medicare in early 2026 did not pay for GLP-1 for obesity treatment, and coverage under Medicaid varied widely by state.

American medical organizations rescind recognition of diagnosis cited in police custody deaths

American medical organizations have rescinded their recognition of a syndrome whose theory stemmed from discredited research. This article explores the history and implications of "excited delirium syndrome," a medical condition that can reportedly...

Emergency room evaluations may be improved with AI algorithms

Emergency room care teams must make fast and crucial decisions. They must determine if patients need to be admitted or discharged and when to order more tests or not. Researchers have been exploring how often patients died in the week after they were sent home and evaluating how this and other aspects of emergency care decision-making could be improved with AI algorithms to assist decision-makers.

Health problems are being misdiagnosed as perimenopause symptoms

Symptoms of menopause and perimenopause (the premenopause period) can be varied enough that clinicians dismiss them in patients in their mid-30s and onward as just a symptom of hormone level change. In this story, a woman's itching was dismissed as a hormonal change, but after two years and 11 separate doctor consultations, was diagnosed as cancer. (Some users may experience a paywall.)

Not everyone who is a candidate for GLP-1 is choosing to use the drug

One person writes about why, although she's a good fit for the medication on paper, she's decided not to take GLP-1 due to concerns about mental health and other side effects, among other reasons.

Learn how Hollywood tries to get mental health portrayals right

"Entertainment is always the first priority," the director of medical research for "Grey's Anatomy" and "Private Practice" explained in this Newsweek article. But, medical consultants and dedicated groups like the University of Southern California's Hollywood, Health, and Society program, can help inform shows' characters, actions, and sensitivities on subjects like mental illness.

Homes in areas increasingly prone to natural disasters often aren't covered by private insurance

Instead, they're often covered under insurance plans of last resort, known as FAIR (Fair Access to Insurance Requirements) plans. However, as more and more homes become covered by FAIR, the program is facing strain. This interactive visual helps explain the new problems FAIR is facing.

The lack of guidance on getting off GLP-1s leaves patients at risk

Dr. David Kessler, former FDA Commissioner and public health leader, explores how these drugs override the brain’s reward-driven eating habits but have notable side effects. These include developing eating disorders, muscle loss, and intestinal obstruction.

People with schizophrenia have triple the risk of developing diabetes

It remains contentious if something inherent about the disease or antipsychotics' side effects (weight gain) are mostly to blame. Some newly diagnosed schizophrenia patients already have insulin resistance, raising questions about if patients' brains are getting enough energy from glucose, and if dietary changes—like a high-fat, low-carbohydrate, moderate-protein diet—may help alleviate symptoms.

Prisoners granted compassionate release due to severe illness often stay months—or years—largely because nursing homes are reluctant to take prisoners.

Fiji's 'quiet' diabetes crisis

Across the Pacific archipelago of Fiji, diabetes often avoids diagnosis until amputation or death is imminent. Fiji's government has said nearly 30% of its population has diabetes, and, in 2019, related amputations accounted for 40% of the country's hospital operations. This "sugar disease" may have such a stronghold on the archipelago, which has a physically active culture that prizes locally sourced foods, due to cost, with processed foods being much cheaper than alternatives.

Risks of GLP-1s include health side effects, counterfeit drugs, and more

This episode interviews researchers and patients who have used semaglutide to explore some of the potential risks associated with using the drug to lose weight. These include insurance challenges, health scares related to counterfeit versions of these drugs, and some users lose their ability to enjoy food.

The popularity of new weight loss drugs has led to a diabetes treatment shortage

The FDA approved Ozempic to help patients with diabetes, but the popularity of semaglutide as a weight loss drug led doctors to prescribe Ozempic to nondiabetic patients who needed to lose weight. Ozempic became so popular that manufacturers could not keep pace with demand, posing risks for Ozempic-users with diabetes.

How dentistry evolved from carnival sideshow to respected medicine

The field, which has remained siloed from other medical care, also has a separate insurance system. This podcast walks through how and why dental insurance often remains capped at $1,500 primarily to cover cleanings, and it wouldn't cover catastrophes—unlike many other medical or housing insurance models.

Telehealth demand for GLP-1s is on the rise as people seek it out for myriad reasons—the proportion of non-obesity and non-diabetes-related prescriptions for the drug soared from 4.5% in 2018 to 17% in 2023.

Some UK doctors pushed for broad 'do not resuscitate' orders for autistic adults during COVID

The controversial push was to create such orders without individuals' or their families' consent, underscoring modern-day prejudice against people on the spectrum.

GLP-1s are linked to reduced worker illness and cost savings—a 2026 economic analysis finds the weight-loss drugs are tied to a 17% drop in worker sick leave days.

DBS effectiveness in treating addiction remains uncertain amid inconsistent results

Critics argue that deep brain stimulation should be considered a last resort and not a scalable solution, given its high costs and trials limited to small samples. However, it has helped some patients manage severe opioid use disorder when conventional methods didn’t work.

Mental illness in the US costs roughly $282B annually nationwide.

Implanted neurotechnology can leave users vulnerable when manufacturers go under

Despite providing relief from neurological conditions, patients are left stranded when the companies that make these devices shut down. The lack of regulation means patients often face technical failure, insurance battles, or risky surgeries to maintain their quality of life.

Black women offer a solution to racial health disparities

Black women in the US face higher rates of obesity, heart disease and more diseases. This article explores the historical and systemic racism underpinning the disparity, and the solutions Black women are creating.

Critics of concierge medicine argue it's worsening physician shortages and expanding inequity

Some research suggests that the average wait time for a primary care visit in major US cities can be 21 days. Subscription-based medical practices offer faster in-person and virtual appointment options, but the price barrier to this type of service may worsen inequity in healthcare access. (Some users may experience a paywall.)

Debunking myths about weight loss drugs

Business Insider delves into the research on GLP-1 to highlight the good and bad aspects other stories overlook. Few make it clear that GLP-1 drugs simply don’t work for many people. This deep dive raises a number of questions about the future of GLP-1 and how they will be used.

How weight loss drugs could reduce obesity costs

A detailed analysis from finance giant ING finds semaglutide and other weight loss drugs could significantly drive down global costs stemming from heart disease and other health problems associated with obesity. The benefits will vary, depending on each country’s demographics and drug and healthcare costs.

Dozens of US women in labor turned away from hospital between 2022 and 2024

An Associated Press analysis of federal hospital investigation data concluded that more than 100 pregnant women in medical distress were turned away from emergency rooms or treated negligently since 2022.

Why might someone want to stay in psychosis?

Author Abigail Gosselin writes that her verbal auditory hallucination, often assumed by others to be harmful or threatening in nature, offered a salve to loneliness, even as it told her to kill herself. This perceived benefit and others Gosselin shares offer insight into why people in psychosis may struggle to adhere to treatment and medication plans.

The overlooked physical causes of insomnia

Persistent lack of sleep is dangerous for anyone, but women are especially unlikely to have their symptoms taken seriously. This article highlights the physical causes of insomnia—a condition often written off as solely psychological—and the importance of early diagnosis. The writer, Courtney Maum, was diagnosed with an anterior nasal valve collapse as the source of her insomnia.

Read a study about racial differences in Lyme disease diagnosis

The research published in September 2025 examined differences in Lyme disease diagnosis among Medicaid and Medicare beneficiaries using data from 2016 to 2021. It notes that though US Lyme disease surveillance data indicates more than 90% of diagnosed Lyme cases are among white people, people of color—particularly those who identify as Black or African American—have higher rates of more severe disease of Lyme, with symptoms including arthritis and neurologic impacts.

Food companies are exploring 'GLP-1 friendly' diet labels

Producers of foods like Healthy Choice frozen meals are placing "GLP-1 friendly" labels on their food, but there's no regulation about what that label means. Nutritionists say that GLP-1s can help reduce appetite, but healthy, balanced diets are a necessary complement to the medications. Data shows that about half of GLP-1 users quit these medications within a year and then rapidly regain weight, underscoring the importance of also prioritizing healthy eating.

Most life insurance policies cover death by natural causes or accidents

However, some other causes aren’t always covered. Suicide in the first two years of coverage, high-risk activities or jobs, and war or terrorism aren’t typically covered by life insurance, for instance. However, some added benefits (or “riders”) can account for some of these situations.